glp-1/gip receptor agonists Understand Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy Frontiers | Clinical perspectives on

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for the treatment of type 2 diabetes and, more recently, for weight management among individuals without diabetes

Alcohol is a known gastric irritant that can independently increase burping, bloating, and digestive discomfort

Retatrutide Clinical Trial Results: The Data Phase 3 TRIUMPH-4 Trial (December 2025) The TRIUMPH-4 Phase 3 study enrolled 445 participants with obesity or overweight who also had knee osteoarthritis

Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1) Proceedings of the National Academy of Sciences of the United States of America

Nature 379: 69-72, 1996

Just a simpler approach to weight loss